6533b82dfe1ef96bd1290a78

RESEARCH PRODUCT

qFIBS: A Novel Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis

George Boon-bee GohPik-eu Jason ChangDina TiniakosDina TiniakosQin WangLai WeiLai WeiChee-kiat TanWei-keat WanHuiying RaoElisabetta BugianesiKiat Hon LimSalvatore PettaQuentin M. AnsteeQuentin M. AnsteeWei Qiang LeowJingmin ZhaoAileen WeeXiaoxiao WangManuel Romero-gómezFeng LiuStephen A. Harrison

subject

Liver CirrhosisMale0301 basic medicineBiopsyChronic liver diseaseSeverity of Illness IndexGastroenterologyHepatitis0302 clinical medicineNon-alcoholic Fatty Liver DiseaseFibrosisNonalcoholic fatty liver diseaseqFibrosisNASH; automated; qFIBS; qFibrosis; quantitative evaluationNASH FIBROSISmedicine.diagnostic_testNASHMiddle AgedReference Standards3. Good healthLiverDimensional Measurement AccuracyLiver biopsyFemale030211 gastroenterology & hepatologyAlgorithmsmedicine.medical_specialtydigestive systemWhite People03 medical and health sciencesAsian PeopleInternal medicineImage Interpretation Computer-AssistedSeverity of illnessmedicineHumansqFIBSHepatologyReceiver operating characteristicbusiness.industryReproducibility of Resultsmedicine.diseasequantitative evaluationdigestive system diseasesConfidence intervalFatty Liver030104 developmental biologyautomatedSteatosisbusiness

description

[Background and Aims] Nonalcoholic steatohepatitis (NASH) is a common cause of chronic liver disease. Clinical trials use the NASH Clinical Research Network (CRN) system for semiquantitative histological assessment of disease severity. Interobserver variability may hamper histological assessment, and diagnostic consensus is not always achieved. We evaluate a second harmonic generation/two‐photon excitation fluorescence (SHG/TPEF) imaging‐based tool to provide an automated quantitative assessment of histological features pertinent to NASH.

10.1002/hep.30986http://dx.doi.org/10.1002/hep.30986